review Open AccessTop 1% cited
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
Annals of the Rheumatic Diseases · 2016 · Vol. 75(5) · pp. 795–810
Carina Gøtestam Skorpen(Norwegian University of Science and Technology)Maria Hoeltzenbein(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)Anǵela Tincani(University of Brescia)Rebecca Fischer‐Betz(Düsseldorf University Hospital)Élisabeth Éléfant(Sorbonne Université)Christina Chambers(University of California San Diego)José António Pereira da Silva(University of Coimbra)Catherine Nelson‐Piercy(St Thomas' Hospital)Irene Cetin(University of Milan)N. Costedoat‐Chalumeau(Délégation Paris 5)Radboud J. E. M. Dolhain(Erasmus MC)Frauke Förger(University Hospital of Bern)Munther A. Khamashta(St Thomas' Hospital)Guillermo Ruiz‐Irastorza(University of the Basque Country)A. Zink(German Rheumatism Research Centre)Jiří Vencovský(Institute of Rheumatology)Maurizio Cutolo(University of Genoa)N. CaeyersClaudia Zumbühl(European League Against Rheumatism)Monika Østensen✉(Norwegian University of Science and Technology)
Pregnancy and Medication ImpactReproductive System and PregnancyEosinophilic EsophagitisMedicinePregnancyRituximabTocilizumabDiscontinuationSulfasalazineAzathioprineIntensive care medicineInternal medicineRheumatoid arthritis
MeSH terms
Abnormalities, Drug-InducedBiological ProductsDelphi TechniqueFemaleHumansInfant, NewbornLactationMaternal-Fetal ExchangePregnancyPregnancy ComplicationsPregnancy OutcomePrenatal Exposure Delayed EffectsRheumatic DiseasesPreconception CareAntirheumatic Agents
Funding
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Sanofi
- Teva Pharmaceutical Industries
- Celgene
- Celltrion
- King's College London
- King's Health Partners
- Università degli Studi di Brescia
- Swedish Orphan Biovitrum
- Medac
- LEO Pharma
- Genentech
- Chugai Pharmaceutical
Citations
1,034
FWCI
92.00
field-weighted impact
References
104
Percentile
100%
vs. same field & year
Citations per year
Cited by
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Kidney International · 2024 · 6,803 citations
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
Annals of the Rheumatic Diseases · 2016 · 875 citations
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
Annals of the Rheumatic Diseases · 2019 · 779 citations
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Gut · 2019 · 2,254 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Annals of the Rheumatic Diseases · 2017 · 5,757 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Annals of the Rheumatic Diseases · 2020 · 2,709 citations
References
The Levels of Evidence and Their Role in Evidence-Based Medicine
Plastic & Reconstructive Surgery · 2011 · 2,090 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.